ACLX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Arcellx Inc

NASDAQ | ACLX

86.92

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 14, 2025)

$4.78B

Market Cap

-

P/E Ratio

-3.41

EPS

$107.37

52 Week High

$47.86

52 Week Low

HEALTHCARE

Sector

ACLX Chart

Recent Chart
Price Action

ACLX Technicals

Tags:

ACLX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $108M
Total Revenue $108M
Cost Of Revenue $5.2M
Costof Goods And Services Sold $5.2M
Operating Income -$138M
Selling General And Administrative $88M
Research And Development $157M
Operating Expenses $240M
Investment Income Net -
Net Interest Income $32M
Interest Income $33M
Interest Expense $1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.2M
Income Before Tax -$105M
Income Tax Expense $2.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$107M
Comprehensive Income Net Of Tax -
Ebit -$104M
Ebitda -$99M
Net Income -$107M

Revenue & Profitability

Earnings Performance

ACLX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $711M
Total Current Assets $599M
Cash And Cash Equivalents At Carrying Value $106M
Cash And Short Term Investments $106M
Inventory -
Current Net Receivables -
Total Non Current Assets $112M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $38M
Short Term Investments $482M
Other Current Assets $12M
Other Non Current Assets -
Total Liabilities $257M
Total Current Liabilities $125M
Current Accounts Payable $2.1M
Deferred Revenue -
Current Debt -
Short Term Debt $15M
Total Non Current Liabilities $131M
Capital Lease Obligations $54M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $54M
Other Current Liabilities $49M
Other Non Current Liabilities $8.6M
Total Shareholder Equity $455M
Treasury Stock -
Retained Earnings -$497M
Common Stock $53K
Common Stock Shares Outstanding $54M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$83M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $5.2M
Capital Expenditures $13M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$183M
Cashflow From Financing -$24M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $1.2M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$107M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $108M
Total Revenue $108M
Cost Of Revenue $5.2M
Costof Goods And Services Sold $5.2M
Operating Income -$138M
Selling General And Administrative $88M
Research And Development $157M
Operating Expenses $240M
Investment Income Net -
Net Interest Income $32M
Interest Income $33M
Interest Expense $1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.2M
Income Before Tax -$105M
Income Tax Expense $2.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$107M
Comprehensive Income Net Of Tax -
Ebit -$104M
Ebitda -$99M
Net Income -$107M

ACLX News

ACLX Profile

Arcellx Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Arcellx, Inc. (ACLX) is a clinical-stage biotechnology firm based in Gaithersburg, Maryland, specializing in innovative immunotherapy solutions aimed at addressing challenging oncological and other intractable diseases. With a robust pipeline focused on advancing novel therapies, Arcellx is committed to transforming patient treatment paradigms through its proprietary technologies. The company’s dynamic research efforts underscore its dedication to enhancing patient outcomes and expanding therapeutic options in the oncology landscape.

VHAI
+66.66%
$0.00
UGRO
+62.59%
$0.60
CGBS
-39.47%
$0.03
BURU
-23.61%
$0.39
YYAI
-18.17%
$0.13
BITF
+8.44%
$5.84
NVDA
-2.55%
$183.50
TMQ
+47.56%
$9.68
PLUG
-0.25%
$3.89
NVTS
+30.49%
$13.00
CAN
+17.03%
$1.77
SSKN
+44.75%
$2.22
DNN
+6.33%
$3.27
RGTI
+2.13%
$56.08
ITP
+23.88%
$0.32
BYND
-22.70%
$0.80
LAES
+16.88%
$7.16
EDHL
+91.46%
$0.95
INTC
-2.12%
$36.42
AXDX
-61.36%
$0.03
CRML
+21.88%
$28.37
MNTS
+16.08%
$1.66
NAK
+2.81%
$2.73
IONZ
+6.95%
$2.46
SOUN
+10.25%
$19.14
DFLI
+44.03%
$1.57
F
+1.42%
$11.70
ONDS
+17.24%
$10.81
RR
+8.95%
$6.45
AMD
+2.99%
$222.90
DVLT
+15.00%
$1.95
WULF
+12.67%
$15.77
GPUS
-7.04%
$0.39
ETHD
+5.70%
$3.52
NUAI
+42.55%
$3.35
ERIC
+20.26%
$9.82
ACHR
+0.64%
$12.85
KDLY
-1.56%
$0.85
MARA
+9.33%
$22.12
UUUU
+11.50%
$26.50
RXRX
-0.99%
$5.47
QBTS
+5.48%
$42.84
TLRY
-4.43%
$1.61
UAMY
+9.24%
$18.25
JDZG
+37.23%
$2.58
BBD
+2.58%
$3.17
RMBL
+60.50%
$3.21
TSLA
-1.38%
$429.85
ADD
-25.47%
$0.05
AREC
+29.11%
$6.43
BTBT
+7.12%
$4.28
RIG
-1.87%
$3.14
CLSK
+9.75%
$21.99
SRM
+53.27%
$10.30
PLTR
+2.50%
$181.65
ADAP
-11.93%
$0.15
SOFI
+2.18%
$27.73
NIO
-3.06%
$6.95
CIFR
+1.65%
$20.67
JOBY
+5.63%
$17.71
USAR
-0.86%
$38.34
NOK
+4.57%
$5.49
IREN
+6.40%
$68.25
CLF
+0.72%
$13.93
WWR
+14.25%
$2.92
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
APLD
+9.34%
$37.44
AAL
+2.51%
$12.03
WLGS
-5.57%
$0.04
QS
-2.14%
$16.62
GGB
+2.85%
$3.24
MP
+2.98%
$97.90
ETWO
0.00%
$3.30
ASST
-4.16%
$1.03
BMNR
-5.11%
$53.94
ASPI
+31.49%
$13.32
BTG
+0.74%
$5.34
AMC
-2.71%
$2.87
EOSE
+2.55%
$17.48
SNAP
-0.93%
$7.97
QUBT
-0.04%
$21.45
AMZN
-0.61%
$218.72
ABAT
+7.76%
$9.93
GWH
-14.18%
$7.76
AFMD
-34.94%
$0.18
NAKA
-6.15%
$0.80
GWAV
+84.53%
$15.70
NB
+4.41%
$11.81
BCRX
-10.95%
$6.26
RGTZ
-0.34%
$9.26
RF
+1.91%
$25.03
ABEV
+1.36%
$2.16
SLDP
+7.50%
$6.30
OPI
-16.97%
$0.20
ATXS
+38.78%
$11.75
WFC
+7.55%
$84.88
PYPL
-1.40%
$68.86
KLG
-9.05%
$13.35
HPE
+1.18%
$25.09
VHAI
+66.66%
$0.00
UGRO
+62.59%
$0.60
CGBS
-39.47%
$0.03
BURU
-23.61%
$0.39
YYAI
-18.17%
$0.13
BITF
+8.44%
$5.84
NVDA
-2.55%
$183.50
TMQ
+47.56%
$9.68
PLUG
-0.25%
$3.89
NVTS
+30.49%
$13.00
CAN
+17.03%
$1.77
SSKN
+44.75%
$2.22
DNN
+6.33%
$3.27
RGTI
+2.13%
$56.08
ITP
+23.88%
$0.32
BYND
-22.70%
$0.80
LAES
+16.88%
$7.16
EDHL
+91.46%
$0.95
INTC
-2.12%
$36.42
AXDX
-61.36%
$0.03
CRML
+21.88%
$28.37
MNTS
+16.08%
$1.66
NAK
+2.81%
$2.73
IONZ
+6.95%
$2.46
SOUN
+10.25%
$19.14
DFLI
+44.03%
$1.57
F
+1.42%
$11.70
ONDS
+17.24%
$10.81
RR
+8.95%
$6.45
AMD
+2.99%
$222.90
DVLT
+15.00%
$1.95
WULF
+12.67%
$15.77
GPUS
-7.04%
$0.39
ETHD
+5.70%
$3.52
NUAI
+42.55%
$3.35
ERIC
+20.26%
$9.82
ACHR
+0.64%
$12.85
KDLY
-1.56%
$0.85
MARA
+9.33%
$22.12
UUUU
+11.50%
$26.50
RXRX
-0.99%
$5.47
QBTS
+5.48%
$42.84
TLRY
-4.43%
$1.61
UAMY
+9.24%
$18.25
JDZG
+37.23%
$2.58
BBD
+2.58%
$3.17
RMBL
+60.50%
$3.21
TSLA
-1.38%
$429.85
ADD
-25.47%
$0.05
AREC
+29.11%
$6.43
BTBT
+7.12%
$4.28
RIG
-1.87%
$3.14
CLSK
+9.75%
$21.99
SRM
+53.27%
$10.30
PLTR
+2.50%
$181.65
ADAP
-11.93%
$0.15
SOFI
+2.18%
$27.73
NIO
-3.06%
$6.95
CIFR
+1.65%
$20.67
JOBY
+5.63%
$17.71
USAR
-0.86%
$38.34
NOK
+4.57%
$5.49
IREN
+6.40%
$68.25
CLF
+0.72%
$13.93
WWR
+14.25%
$2.92
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
APLD
+9.34%
$37.44
AAL
+2.51%
$12.03
WLGS
-5.57%
$0.04
QS
-2.14%
$16.62
GGB
+2.85%
$3.24
MP
+2.98%
$97.90
ETWO
0.00%
$3.30
ASST
-4.16%
$1.03
BMNR
-5.11%
$53.94
ASPI
+31.49%
$13.32
BTG
+0.74%
$5.34
AMC
-2.71%
$2.87
EOSE
+2.55%
$17.48
SNAP
-0.93%
$7.97
QUBT
-0.04%
$21.45
AMZN
-0.61%
$218.72
ABAT
+7.76%
$9.93
GWH
-14.18%
$7.76
AFMD
-34.94%
$0.18
NAKA
-6.15%
$0.80
GWAV
+84.53%
$15.70
NB
+4.41%
$11.81
BCRX
-10.95%
$6.26
RGTZ
-0.34%
$9.26
RF
+1.91%
$25.03
ABEV
+1.36%
$2.16
SLDP
+7.50%
$6.30
OPI
-16.97%
$0.20
ATXS
+38.78%
$11.75
WFC
+7.55%
$84.88
PYPL
-1.40%
$68.86
KLG
-9.05%
$13.35
HPE
+1.18%
$25.09
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.